1661P Antitumor efficacy and immune profiling of the mouse ortholog of nemvaleukin alfa, a novel engineered IL-2 fusion protein, in an orthotopic mouse model of small cell lung cancer alone or in combination with standard chemotherapy

1661P Antitumor efficacy and immune profiling of the mouse ortholog of nemvaleukin alfa, a novel engineered IL-2 fusion protein, in an orthotopic mouse model of small cell lung cancer alone or in combination with standard chemotherapy

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 32; p. S1169
Main Authors: Pan, Y., Zhang, H., Chen, T., Ding, H., Han, H., Almonte, C., Labbe, K.E., Nguyen, S., Lopes, J.E., Losey, H.C., Winquist, R.J., Wong, K-K.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-09-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2021.08.245